Thursday, December 12, 2024

Why FLGC is Making Headlines Today

A Message on Behalf of Flora Growth Corp.

NASDAQ cannabis company is targeting a $4 billion market by launching its parallel import business in Germany! 

Emerging cannabis firm has a vision to become a market leader in the European pharmaceutical and medical cannabis market. 


This growing company has recently launched its parallel import business ("PI Business") in Germany and the European Union ("EU"). According to the European Affordable Medicines, the size of Germany's parallel import business, including exports, is close to $4 billion with 47% of exports to EU countries coming from Germany. 


This strategic expansion underscores their broadening footprint in key international markets and is just one reason why one firm has a $6 price target!


See how this company is addressing both domestic and international markets to become a key cannabis player.


This message is a paid advertisement for Flora Growth Corp. from Interactive Offers. Schaeffer's Investment Research Inc. receives a fixed fee for each subscriber that clicks on a link in this email. Other than the compensation received for this advertisement sent to subscribers, Schaeffer's Investment Research Inc. and its principals are not affiliated with Flora Growth Corp. Schaeffer's Investment Research Inc. and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither Schaeffer's Investment Research Inc. nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Schaeffer's Investment Research Inc. to buy or sell any security. Schaeffer's Investment Research Inc. has not evaluated the accuracy of any claims made in this advertisement. Schaeffer's Investment Research Inc. recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Flora Growth Corp. on Flora Growth Corp. website for additional information.


No comments:

Post a Comment

Breaking | Why Chanel Chose Matthieu Blazy

BREAKING NEWS   Why Chanel Chose Matthieu Blazy By Robert Williams The designer, fresh off a star turn leadi...